NHSPI_measure_metadata: 98
Data source: Big Local News · About: big-local-datasette
rowid | obsid | index | item_code | domain_code | domain_name | domain_description | subdomain_code | subdomain_name | subdomain_description | subdomain_long_desc | measure_name | measure_description | measure_rationale | data_source | verbose_data_source | data_dates | limitations |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
98 | 224.0 | Index | 5.2.1 | 5.0 | CM | Countermeasure Management | 16.0 | CUE | Countermeasure Utilization & Effectiveness | The level to which the community has achieved preparedness for vaccination and immunization and the level to which the community completes a course of countermeasure usage or follows through in the use of an intervention. This also covers the resultant outcome from the appropriate use of the intervention. | M24 | Percent of children ages 19-35 months in the state receiving recommended routine childhood vaccinations, including four or more doses of diphtheria, tetanus, and pertussis vaccine, three or more doses of poliovirus vaccine, one or more doses of any measles-containing vaccine, and three or more doses of Hepatitis B vaccine | The measure is used by the Centers for Disease Control and Prevention (CDC) and states to monitor health status and is an important measure of achievement of immunization program objectives. The measure is a pre-event indicator of the capacity of the state's public and private immunization infrastructure needed to respond to an emerging vaccine-controllable disease. | CDC NIS | Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHC), National Immunization Survey (NIS) | 2012—2017 | The measure evaluates routine vaccines for preventable disease in pre-school age children, and may not reflect the vaccination rate for a severe emerging disease. |